Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002312372 | SCV000846612 | uncertain significance | Inborn genetic diseases | 2016-05-17 | criteria provided, single submitter | clinical testing | The p.L2283P variant (also known as c.6848T>C), located in coding exon 22 of the NSD1 gene, results from a T to C substitution at nucleotide position 6848. The leucine at codon 2283 is replaced by proline, an amino acid with similar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV003231601 | SCV002789775 | uncertain significance | Sotos syndrome | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003231601 | SCV003254152 | likely benign | Sotos syndrome | 2022-03-09 | criteria provided, single submitter | clinical testing |